Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia.
Wei-Kei WongWah-Kheong ChanShubash Shander GanapathySoo-Kun LimPublished in: Seminars in dialysis (2022)
A high prevalence of MAFLD and advanced liver fibrosis was observed among hemodialysis patients. Nephrologists should consider a more proactive approach in diagnosing MAFLD and/or advanced liver fibrosis in hemodialysis patients.
Keyphrases